Detailed information for compound 987324

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 345.419 | Formula: C16H19N5O2S
  • H donors: 4 H acceptors: 3 LogP: 1.09 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: NC(=O)Nc1sc(cc1C(=O)N[C@H]1CCCNC1)c1cccnc1
  • InChi: 1S/C16H19N5O2S/c17-16(23)21-15-12(14(22)20-11-4-2-6-19-9-11)7-13(24-15)10-3-1-5-18-8-10/h1,3,5,7-8,11,19H,2,4,6,9H2,(H,20,22)(H3,17,21,23)/t11-/m0/s1
  • InChiKey: GCSKSASBAPPULE-NSHDSACASA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens checkpoint kinase 1 Starlite/ChEMBL References
Homo sapiens cyclin-dependent kinase 2 associated protein 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum Serine/threonine-protein kinase Chk1, putative Get druggable targets OG5_130454 All targets in OG5_130454
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase Get druggable targets OG5_130454 All targets in OG5_130454
Brugia malayi Protein kinase domain containing protein Get druggable targets OG5_130454 All targets in OG5_130454
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_130454 All targets in OG5_130454
Brugia malayi hypothetical protein Get druggable targets OG5_134982 All targets in OG5_134982

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trichomonas vaginalis WD repeat domain phosphoinositide-interacting protein, putative cyclin-dependent kinase 2 associated protein 1 87 aa 72 aa 31.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni deleted in oral cancer 1/cdk2-associated protein-like 0.0188 0.3025 0.9182
Leishmania major hypothetical protein, unknown function 0.0033 0.0486 0.5
Toxoplasma gondii hypothetical protein 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Toxoplasma gondii transporter, cation channel family protein 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Echinococcus multilocularis short transient receptor potential channel 6 0.0035 0.0522 0.0143
Trypanosoma brucei Voltage-dependent calcium channel subunit, putative 0.0033 0.0486 0.5
Echinococcus multilocularis transient receptor potential cation channel 0.0035 0.0522 0.0143
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Schistosoma mansoni transient receptor potential channel 0.0033 0.0486 0.000000095145
Trypanosoma cruzi Voltage-dependent calcium channel subunit, putative 0.0033 0.0486 0.5
Leishmania major hypothetical protein, conserved 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Toxoplasma gondii 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Brugia malayi olfactory channel protein osm-9 0.0035 0.0522 0.0038
Echinococcus multilocularis transient receptor potential cation channel 0.0033 0.0486 0.00000010363
Loa Loa (eye worm) hypothetical protein 0.0033 0.0486 0.000000095145
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Echinococcus granulosus transient receptor potential cation channel 0.0033 0.0486 0.00000010363
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Echinococcus granulosus calcium activated potassium channel 0.0033 0.0495 0.0036
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Echinococcus granulosus transient receptor potential cation channel 0.0035 0.0522 0.0143
Echinococcus multilocularis transient receptor potential cation channel 0.0035 0.0522 0.0143
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0033 0.0486 0.5
Loa Loa (eye worm) hypothetical protein 0.0035 0.0522 0.0131
Schistosoma mansoni transient receptor potential channel 0.0033 0.0486 0.000000095145
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Trypanosoma brucei inositol 1,4,5-trisphosphate receptor 0.0033 0.0486 0.5
Toxoplasma gondii hypothetical protein 0.0033 0.0486 0.5
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Toxoplasma gondii transporter, cation channel family protein 0.0033 0.0486 0.5
Loa Loa (eye worm) hypothetical protein 0.0188 0.3025 0.9182
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Echinococcus granulosus Cyclin dependent kinase 2 associated protein 0.0188 0.3025 1
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.0202 0.3251 1
Onchocerca volvulus Diphthamide biosynthesis protein 7 homolog 0.0188 0.3025 1
Schistosoma mansoni serine/threonine protein kinase 0.0202 0.3251 1
Loa Loa (eye worm) hypothetical protein 0.0033 0.0486 0.000000095145
Echinococcus multilocularis Cyclin dependent kinase 2 associated protein 0.0188 0.3025 1
Echinococcus granulosus transient receptor potential cation channel 0.0033 0.0486 0.00000010363
Schistosoma mansoni transient receptor potential channel 0.0035 0.0522 0.0131
Brugia malayi Protein kinase domain containing protein 0.0202 0.3251 0.2906
Trypanosoma cruzi inositol 1,4,5-trisphosphate receptor, putative 0.0033 0.0486 0.5
Leishmania major calcium channel protein, putative,ion transporter, putative 0.0033 0.0486 0.5
Toxoplasma gondii transporter, cation channel family protein 0.0033 0.0486 0.5
Echinococcus multilocularis calcium activated potassium channel 0.0033 0.0495 0.0036
Giardia lamblia Kinase, NEK 0.0003 0 0.5
Toxoplasma gondii 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein 0.0033 0.0486 0.5
Echinococcus granulosus short transient receptor potential channel 6 0.0035 0.0522 0.0143

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 0.3 uM Abrogation of camptothecin induced cell cycle arrest at G2/M phase in human HT29 cells ChEMBL. 18547806
IC50 (binding) = 0.006 uM Inhibition of Chk1 ChEMBL. 18547806
IC50 (binding) = 3.3 uM Inhibition of Cdk1 ChEMBL. 18547806

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 18547806

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.